What is respiratory failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Respiratory Failure

Respiratory failure is characterized by significant deterioration of arterial blood gas tensions, specifically hypoxemia (PaO2 < 60 mmHg) and/or hypercapnia (PaCO2 > 45 mmHg), resulting from the inability of the respiratory system to maintain adequate gas exchange between ambient air and peripheral organs. 1

Types of Respiratory Failure

Respiratory failure is classified into two main types:

  1. Type I (Hypoxemic) Respiratory Failure:

    • Characterized by hypoxemia (PaO2 < 60 mmHg) with normal or low PaCO2
    • Results primarily from ventilation-perfusion mismatch, intrapulmonary shunting, or diffusion impairment
    • Common causes include pneumonia, pulmonary edema, and acute respiratory distress syndrome (ARDS) 2
  2. Type II (Hypercapnic) Respiratory Failure:

    • Characterized by hypercapnia (PaCO2 > 45 mmHg) and usually accompanied by hypoxemia
    • Results from alveolar hypoventilation or increased dead space ventilation
    • Common causes include COPD exacerbations, neuromuscular disorders, and chest wall deformities 3, 4

Pathophysiological Mechanisms

Several mechanisms contribute to respiratory failure:

  • Ventilation-Perfusion (V'/Q') Mismatch: The most common mechanism, where areas of the lung receive ventilation but inadequate perfusion or vice versa 3

  • Alveolar Hypoventilation: Reduced minute ventilation relative to CO2 production, leading to hypercapnia 4

  • Increased Dead Space Ventilation: Ventilation of non-perfused or poorly perfused lung units, leading to ineffective CO2 elimination 4

  • Intrapulmonary Shunting: Blood passes through the lungs without participating in gas exchange, causing hypoxemia resistant to oxygen therapy 3

  • Diffusion Impairment: Thickening of the alveolar-capillary membrane, limiting oxygen transfer 2

Clinical Manifestations

The clinical presentation of respiratory failure includes:

  • Tachypnea (respiratory rate > 35 breaths/min)
  • Abnormal breathing pattern (decreased tidal volume, increased respiratory frequency)
  • Use of accessory respiratory muscles
  • Cyanosis (in severe hypoxemia)
  • Altered mental status (confusion, somnolence)
  • Tachycardia
  • Hypotension (in severe cases) 3

Diagnostic Criteria

Respiratory failure is diagnosed based on:

  • Arterial Blood Gas Analysis:

    • Type I: PaO2 < 60 mmHg with normal or low PaCO2
    • Type II: PaCO2 > 45 mmHg, usually with hypoxemia 3, 1
  • Pulse Oximetry:

    • SpO2 < 90% suggests significant hypoxemia
    • However, clinical recognition of hypoxemia is not reliable, so continuous monitoring is recommended 3
  • Chest Imaging:

    • May show bilateral infiltrates in ARDS
    • Can be normal or show specific patterns depending on the underlying cause 3

Management Principles

Management of respiratory failure focuses on:

  1. Oxygen Therapy:

    • Target SpO2 92-96% for most patients 5
    • For patients with COPD or risk of hypercapnic failure, target 88-92% 5
    • Delivery devices should be selected based on severity:
      • Mild hypoxemia: Nasal cannula (1-2 L/min)
      • Moderate hypoxemia: Simple face mask (5-6 L/min)
      • Severe hypoxemia: Non-rebreather mask (15 L/min) 5
  2. Ventilatory Support:

    • Non-invasive Ventilation (NIV):

      • First-line for hypercapnic respiratory failure, especially in COPD
      • Can be used in selected cases of hypoxemic failure 1
    • Invasive Mechanical Ventilation:

      • Indicated when NIV fails or is contraindicated
      • Lung-protective strategies should be employed (low tidal volumes, appropriate PEEP) 6
    • High-Flow Nasal Oxygen (HFNO):

      • May reduce intubation rates and improve patient comfort in certain types of respiratory failure 3
  3. Treatment of Underlying Cause:

    • Antibiotics for pneumonia
    • Bronchodilators and corticosteroids for COPD exacerbations
    • Diuretics for cardiogenic pulmonary edema 4

Complications and Prognosis

  • Respiratory failure is associated with significant morbidity and mortality
  • Complications include ventilator-associated pneumonia, barotrauma, and multi-organ dysfunction
  • Prognosis depends on the underlying cause, patient comorbidities, and response to treatment 7
  • Death from refractory respiratory failure is uncommon; most deaths result from multiple organ failure or recurrent sepsis 3

Special Considerations

  • Right Ventricular Function: Respiratory failure can lead to pulmonary hypertension and right heart dysfunction, which should be monitored and managed appropriately 3

  • Mechanical Ventilation Strategy: Should aim to unload the right ventricle by avoiding lung derecruitment and overdistension 3

  • Monitoring: Continuous monitoring of oxygen saturation, respiratory rate, and hemodynamic parameters is essential 3, 5

References

Research

[Respiratory Insufficiency: State of the Art - Diagnosis and Therapy].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory failure in chronic obstructive pulmonary disease.

The European respiratory journal. Supplement, 2003

Guideline

Oxygen Therapy in Pulmonary Arterial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute respiratory failure.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.